Navigation Links
Anti-depressants Do Not Increase the Overall Risk of Most Birth Defects

Two separate studies have revealed that taking SSRIs (selective serotonin reuptake inhibitors), anti-depression drugs , during pregnancy do not significantly increase the overall risk for most birth defects.

However, each study found that taking SSRIs during pregnancy is associated with a small increase in the risk of certain rare birth defects but they are different birth defects.

The studies show how important post-market surveillance is in assessing the safety of medications in pregnancy. During pre-approval, drugs are tested on relatively few subjects and only side effects with a large frequency are detected. Once approved, many people take the medication and even very rare side effects surface, Dr. Michael Katz, acting Medical Director of the March of Dimes, said.

Most prescription drugs are not tested on pregnant women. So we must start monitoring the effects of these medications as soon as they reach consumers, and keep monitoring for as long as it takes to get good data on risks to mothers and babies, Dr. Katz added.

The March of Dimes recommends women discuss the potential risks and benefits of taking SSRIs during pregnancy with their doctors.

Women, who are taking an antidepressant should not stop taking their medications if they discover they are pregnant, but should immediately contact their health care provider. It may be dangerous to stop taking an antidepressant suddenly.

About 10 percent of pregnant women in the United States suffer from depression, some of it undiagnosed.

The studies have been published in The New England Journal of Medicine.


'"/>




Page: 1

Related medicine news :

1. Heart Patients Taking Anti-depressants Have Higher Risk Of Death
2. Anti-depressants may cause stillbirth
3. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
4. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
5. Genetic Tests Could Help Decide the Right Anti-depressants
6. Use of Cellular Phones associated with Increased risk of Brain Tumors
7. Increase in sugar...decrease in brain function!!!
8. Increase in tobacco deaths
9. Increased Heart Attack Risk From Celebrex,Vioxx
10. Deep Sleep Doesnt Increase Memory
11. Allergy Risk Increased by Kerosene Use
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... ... February 13, 2016 , ... ... Data Management Solution Providers list for its expertise in eClinical Solutions. DDi has ... to serve the technology needs of global clients. DDi provides smarter technology for ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... hosted over 250 members of South Florida’s philanthropic community at its 10th anniversary ...
(Date:2/12/2016)... ... 12, 2016 , ... Coco Libre, the maker of coconut water beverages with ... Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic ... The invitation-only gifting suite, held this year at the W Hollywood Hotel, has become ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher ... Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare ... System. This will be the first Fisher House in Nevada, and will provide ...
(Date:2/12/2016)... Pittsburgh, PA (PRWEB) , ... February 12, 2016 ... ... serving families of the Pittsburgh metro area, celebrates the beginning of the latest ... help children develop social skills through art. Donations to this worthy cause are ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... SAN JOSE, Calif. , Feb. 12, 2016  SI-BONE, Inc., ... Implant System ® ("iFuse"), a minimally invasive surgical (MIS) device ... announced that National Government Services, Inc. (NGS), the Medicare Administrative Contractor ... Illinois , Maine , ... Hampshire , New York , ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
Breaking Medicine Technology: